Ambu A/S (OTCMKTS:AMBBY) Trading Down 8.2% – Time to Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares were down 8.2% during mid-day trading on Monday . The stock traded as low as $9.7750 and last traded at $9.7750. Approximately 100 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 689 shares. The stock had previously closed at $10.65.

Ambu A/S Stock Performance

The firm has a market cap of $2.30 billion, a PE ratio of 34.91 and a beta of 1.06. The company has a 50 day simple moving average of $10.86 and a 200-day simple moving average of $12.74. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $246.39 million during the quarter. Ambu A/S had a return on equity of 8.13% and a net margin of 7.81%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.